Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FZY09
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,858
Award facts
- Contract value 100% obligated
- $37,858.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $37,858 by the Defense Logistics Agency on September 26, 2025. The contract covers the supply of Nucala 100 mg/mL auto-injectors, a biologic medication used to treat severe eosinophilic asthma and other eosinophilic conditions. This delivery order was issued without set-aside designation and is scheduled for completion by September 29, 2025, with performance to be fulfilled at the contractor's Park Ridge, Illinois location.
This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.999 billion and valid through November 2026. The parent IDC, established under the SPE2DB program, authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently leveraging its woman-owned small business status to compete effectively for contracts spanning prescription medications, biologics, auto-injectors, and specialized pharmaceutical products across military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FZY09?
SPE2DB25FZY09 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FZY09 worth?
The government has obligated $37,858 on SPE2DB25FZY09.
Is contract SPE2DB25FZY09 an order under another contract?
Yes. SPE2DB25FZY09 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZY09 competed?
The extent of competition for SPE2DB25FZY09 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award